ERBB2 and neoplasm: There is an increasing amount of literature supporting that anti-tumour immunity of anti-neu mAb can be enhanced with immunomodulatory agents such as CD7333, PolyI:C and CpG34 in the highly immunogenic TUBO transplanted WT BALB/c mice.